Viewing Study NCT05528367


Ignite Creation Date: 2025-12-25 @ 12:39 AM
Ignite Modification Date: 2025-12-30 @ 8:32 PM
Study NCT ID: NCT05528367
Status: UNKNOWN
Last Update Posted: 2022-09-06
First Post: 2022-09-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Tirelizumab in Combination With Chemoradiation in Patients With Unresectable Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
Sponsor: Zhejiang Cancer Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module